Pfizer: 2QFY02 net zooms 37% - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Pfizer: 2QFY02 net zooms 37%

Jun 30, 2001

Pfizer has declared an encouraging net profit growth of 37% for 2QFY02 as against 19% growth in sales. Operating margins of the company have shot up to 9.6%.The performance of the company has been better than expected. The third quarter performance is usually the best as sales of cold and cough preparations pick up during this quarter. An increase in operating margins in the second quarter has therefore, come as a pleasant surprise.

(Rs m) 2QFY01 2QFY02 Change
Sales 643 767 19.3%
Other Income 146 154 5.8%
Expenditure 618 693 12.1%
Operating Profit (EBDIT) 25 74 200.8%
Operating Profit Margin (%) 3.8% 9.6%
Interest 1 (1) -160.0%
Depreciation 13 17 31.8%
Profit before Tax 156 211 35.5%
Tax 63 84 32.7%
Profit after Tax/(Loss) 93 127 37.4%
Net profit margin (%) 14.4% 16.6%
No. of Shares (eoy) (m) 11.7 23.4  
Diluted Earnings per share* 31.7 21.7  
P/E (at current price) 14.5 21.1  
(* annualised)      

The better than expected performance seems to be backed by fast growth sales coming from new products, especially Magnex and Hepashield as well as older products maintaining their growth rates. Hepashield and Magnex (hospital antibiotic) launched this year have been ranked as number one and number two highest selling brands respectively.

At the current market price of Rs 458, the stock is trading at a P/e of 21 times its annualised earnings of 2QFY02. The stock has been battered in the last six months due to concerns over the parent's 100% subsidiary.


Equitymaster requests your view! Post a comment on "Pfizer: 2QFY02 net zooms 37%". Click here!

  

More Views on News

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

More Views on News

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Sep 24, 2020 (Close)

TRACK PFIZER

PFIZER - TEVA PHARMA COMPARISON

COMPARE PFIZER WITH

MARKET STATS